Sparsentan and its Impurities

Sparsentan, sold under the brand name Filspari. A medication used to reduce the levels of protein in urine in patients with poor kidney function. Reference standards of Sparsentan API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 15 results for Sparsentan Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 19 2310000

Sparsentan

Sparsentan

  • Catalogue No.:PA 19 2310000

  • CAS :

    254740-64-2

  • Molecular Formula : C32H40N4O5S

  • Molecular Weight : 592.76

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311000

Sparsentan Hydroxy Impurity

Sparsentan Hydroxy Impurity

  • Catalogue No.:PA 19 2311000

  • CAS :

    1201793-64-7

  • Molecular Formula : C21H24N2O5S

  • Molecular Weight : 416.49

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311001

N-(4,5-Dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-4'-(hydroxymethyl)-N-(methoxymethyl)-[1,1'-biphenyl]-2-sulfonamide

N-(4,5-Dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-4'-(hydroxymethyl)-N-(methoxymethyl)-[1,1'-biphenyl]-2-sulfonamide

  • Catalogue No.:PA 19 2311001

  • CAS :

    1098924-76-5

  • Molecular Formula : C23H28N2O6S

  • Molecular Weight : 460.55

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311002

Sparsentan Ethoxy Methyl Acid Impurity Triethylamine Salt

Sparsentan Ethoxy Methyl Acid Impurity Triethylamine Salt

  • Catalogue No.:PA 19 2311002

  • CAS :

    NA

  • Molecular Formula : C29H41N3O7S

  • Molecular Weight : 575.72

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311003

Sparsentan Open Ring Impurity

Sparsentan Open Ring Impurity

  • Catalogue No.:PA 19 2311003

  • CAS :

    1347979-29-6

  • Molecular Formula : C32H42N4O6S

  • Molecular Weight : 610.77

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311004

Sparsentan Methyl Impurity

Sparsentan Methyl Impurity

  • Catalogue No.:PA 19 2311004

  • CAS :

    254741-40-7

  • Molecular Formula : C30H36N4O4S

  • Molecular Weight : 548.7

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311005

Sparsentan N,N-Dimethyl Impurity

Sparsentan N,N-Dimethyl Impurity

  • Catalogue No.:PA 19 2311005

  • CAS :

    NA

  • Molecular Formula : C25H33N3O5S

  • Molecular Weight : 487.62

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311006

4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-N-(methoxymethyl)-[1,1'-biphenyl]-2-sulfonamide

4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-N-(methoxymethyl)-[1,1'-biphenyl]-2-sulfonamide

  • Catalogue No.:PA 19 2311006

  • CAS :

    1026355-73-6

  • Molecular Formula : C34H44N4O6S

  • Molecular Weight : 636.81

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311007

Ethyl 2'-(N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)sulfamoyl)-2-(ethoxymethyl)-[1,1'-biphenyl]-4-carboxylate

Ethyl 2'-(N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)sulfamoyl)-2-(ethoxymethyl)-[1,1'-biphenyl]-4-carboxylate

  • Catalogue No.:PA 19 2311007

  • CAS :

    1247868-68-3

  • Molecular Formula : C25H30N2O7S

  • Molecular Weight : 502.58

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311008

4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-formyl-[1,1'-biphenyl]-2-sulfonamide

4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-formyl-[1,1'-biphenyl]-2-sulfonamide

  • Catalogue No.:PA 19 2311008

  • CAS :

    254737-96-7

  • Molecular Formula : C30H34N4O5S

  • Molecular Weight : 562.69

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311009

4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-2-en-1-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-2-sulfonamide

4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-2-en-1-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-[1,1'-biphenyl]-2-sulfonamide

  • Catalogue No.:PA 19 2311009

  • CAS :

    2567159-90-2

  • Molecular Formula : C32H40N4O5S

  • Molecular Weight : 592.76

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311010

4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(methoxymethyl)-[1,1'-biphenyl]-2-sulfonamide

4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-N-(4,5-dimethylisoxazol-3-yl)-2'-(methoxymethyl)-[1,1'-biphenyl]-2-sulfonamide

  • Catalogue No.:PA 19 2311010

  • CAS :

    254741-35-0

  • Molecular Formula : C31H38N4O5S

  • Molecular Weight : 578.73

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311011

2'-Cyano-4'-methyl-[1,1'-biphenyl]-2-sulfonic Acid

2'-Cyano-4'-methyl-[1,1'-biphenyl]-2-sulfonic Acid

  • Catalogue No.:PA 19 2311011

  • CAS :

    NA

  • Molecular Formula : C14H11NO3S

  • Molecular Weight : 273.31

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311012

2'-(Methoxycarbonyl)-4'-methyl-[1,1'-biphenyl]-2-sulfonic Acid

2'-(Methoxycarbonyl)-4'-methyl-[1,1'-biphenyl]-2-sulfonic Acid

  • Catalogue No.:PA 19 2311012

  • CAS :

    NA

  • Molecular Formula : C15H14O5S

  • Molecular Weight : 306.33

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 2311013

Sparsentan Desethyl Impurity

Sparsentan Desethyl Impurity

  • Catalogue No.:PA 19 2311013

  • CAS :

    254740-63-1

  • Molecular Formula : C30H36N4O5S

  • Molecular Weight : 564.7

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
pharmaffiliates